Low-Dose CT Lung Cancer Screening Programs

Comparison of Inclusion Criteria, Protocol, Baseline and Annual Repeat Screening - Results To Date

	Institution
	Cornell University USA	Hadassah University Israel	Mayo Clinic USA	Moffitt Cancer Center USA	Muenster University Germany	National Cancer Center Hospital Japan	Shinshu University Japan
Inclusion Criteria
Age (yr)	>=60	>=50	>=50	>=45	>=40	>=40	>=40
Smoking History (pack/yr)	>=10	>=10	>=20	>=30	>=20	no	>=0
Fit to Undergo Thoracic Surgery	yes	no	yes	yes	no	no	no
No history of Malignancy	yes	yes	yes¹	yes ²	yes	no	no
Protocol Design
Screening Frequency	yearly	yearly	yearly	yearly	yearly	semiannual	yearly
Number of Patients at Entry	1,000	300	1,520	1,150	1,000	ongoing	7,847
Total Duration (years)	ongoing	3	4	4	4	ongoing	3 years
Baseline Screen
Number of Patients Screened	1,000	340	1,520	172	919	1,707	7,847
Number of Malignancies Detected	27	2	12	1	17	13	40
Stage I Cancers (% total)	81	100	50	100	76	77	83
Annual Repeat Screening
Number of Patients Screened	1,184					9,100	10,045
Number of Malignancies Detected	7				2	21	40
Stage I Cancers (% total)	85				100	81	88
1 No history of congestive heart failure or recent myocardial infarction, no active pulmonary infection, mentally competent. FEV 1/FVC <70%, No recent myocardial infarction, cerebro-vascular accident, surgery or pneumonia, no active pulmonary infection, no pregnancy, no uncontrolled hypertension.

Have questions? Contact us by email, telephone or mail.

Do you need to reach one of our member sites? Search our site locator, or skim our full list of member sites.

I-ELCAP would like thank Idologic, Inc., for its donation of hosting and support services.